Johnson & Johnson (JNJ) Valuation Rose While Beech Hill Advisors Has Lowered Its Position by $3.47 Million; Incyte (INCY) Shareholder Frontier Capital Management Co Decreased Position by $17.90 Million

February 19, 2018 - By Michael Collier

Frontier Capital Management Co Llc decreased its stake in Incyte Corporation (INCY) by 14.69% based on its latest 2017Q3 regulatory filing with the SEC. Frontier Capital Management Co Llc sold 154,311 shares as the company’s stock rose 9.08% with the market. The institutional investor held 896,229 shares of the commercial physical & biological resarch company at the end of 2017Q3, valued at $104.63 million, down from 1.05 million at the end of the previous reported quarter. Frontier Capital Management Co Llc who had been investing in Incyte Corporation for a number of months, seems to be less bullish one the $18.16B market cap company. The stock increased 0.51% or $0.44 during the last trading session, reaching $86.03. About 2.47 million shares traded or 46.16% up from the average. Incyte Corporation (NASDAQ:INCY) has risen 72.84% since February 19, 2017 and is uptrending. It has outperformed by 56.14% the S&P500.

Beech Hill Advisors Inc decreased its stake in Johnson & Johnson (JNJ) by 80.22% based on its latest 2017Q3 regulatory filing with the SEC. Beech Hill Advisors Inc sold 26,665 shares as the company’s stock rose 6.85% with the market. The institutional investor held 6,575 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $855,000, down from 33,240 at the end of the previous reported quarter. Beech Hill Advisors Inc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $357.71B market cap company. The stock increased 1.46% or $1.92 during the last trading session, reaching $133.15. About 7.97 million shares traded or 6.53% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since February 19, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson had 89 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Buy” rating by BMO Capital Markets on Tuesday, October 17. Jefferies maintained Johnson & Johnson (NYSE:JNJ) rating on Tuesday, March 15. Jefferies has “Hold” rating and $99 target. As per Tuesday, June 14, the company rating was maintained by Jefferies. The stock of Johnson & Johnson (NYSE:JNJ) has “Hold” rating given on Monday, October 2 by Piper Jaffray. The rating was maintained by S&P Research on Wednesday, October 14 with “Buy”. The company was maintained on Wednesday, July 20 by RBC Capital Markets. The firm has “Buy” rating given on Tuesday, July 18 by BMO Capital Markets. As per Monday, September 25, the company rating was initiated by Citigroup. The rating was maintained by Argus Research with “Buy” on Wednesday, April 20. The firm earned “Sell” rating on Friday, July 21 by Atlantic Securities.

Investors sentiment is 0.83 in 2017 Q3. Its the same as in 2017Q2. It is the same, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. 11,611 are held by Spc Inc. 3,446 are held by Biondo Investment Advsr Llc. Amg Tru National Bank holds 16,011 shares or 0.14% of its portfolio. Independent Franchise Prns Llp holds 7.49% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 6.43 million shares. Kemnay Advisory Service holds 500 shares or 0.03% of its portfolio. Geode Cap Mngmt Limited Liability Com invested in 29.58 million shares. Wasatch Incorporated stated it has 0.15% in Johnson & Johnson (NYSE:JNJ). Schnieders Cap Management Limited Liability Corporation reported 3.23% in Johnson & Johnson (NYSE:JNJ). Marshall & Sullivan Wa has invested 3.78% in Johnson & Johnson (NYSE:JNJ). Gilman Hill Asset Limited Liability Corp invested in 12,601 shares. Cap Management Va stated it has 0.27% in Johnson & Johnson (NYSE:JNJ). Professional Advisory owns 3.26% invested in Johnson & Johnson (NYSE:JNJ) for 117,588 shares. First Long Island Ltd Co invested in 1.86% or 98,659 shares. Raymond James Trust Na has invested 1.43% of its portfolio in Johnson & Johnson (NYSE:JNJ). Bouchey Financial Grp Incorporated Ltd holds 0.14% or 3,389 shares.

Since August 29, 2017, it had 1 insider buy, and 7 sales for $292,287 activity. Siegel Eric H. also sold $250,068 worth of Incyte Corporation (NASDAQ:INCY) on Friday, September 1. $13.20 million worth of Incyte Corporation (NASDAQ:INCY) was bought by BAKER BROS. ADVISORS LP on Friday, September 8. $263,875 worth of stock was sold by Stein Steven H on Tuesday, August 29. $88,715 worth of Incyte Corporation (NASDAQ:INCY) shares were sold by Flannelly Barry P. 6,760 Incyte Corporation (NASDAQ:INCY) shares with value of $668,361 were sold by GRYSKA DAVID W. Shares for $415,230 were sold by Trower Paul on Tuesday, September 5.

Among 24 analysts covering Incyte (NASDAQ:INCY), 20 have Buy rating, 0 Sell and 4 Hold. Therefore 83% are positive. Incyte had 78 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, February 15 by BMO Capital Markets. The stock of Incyte Corporation (NASDAQ:INCY) has “Outperform” rating given on Wednesday, October 12 by RBC Capital Markets. BMO Capital Markets maintained the shares of INCY in report on Friday, July 21 with “Buy” rating. Nomura maintained the shares of INCY in report on Tuesday, October 6 with “Buy” rating. The rating was maintained by Oppenheimer with “Hold” on Tuesday, May 30. As per Friday, February 12, the company rating was maintained by Oppenheimer. The rating was upgraded by Raymond James to “Outperform” on Thursday, September 29. J.P. Morgan maintained Incyte Corporation (NASDAQ:INCY) on Tuesday, August 1 with “Buy” rating. The rating was maintained by Brean Capital on Wednesday, August 5 with “Buy”. The stock has “Hold” rating by Oppenheimer on Tuesday, June 6.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.02, from 1.02 in 2017Q2. It improved, as 39 investors sold INCY shares while 161 reduced holdings. 59 funds opened positions while 149 raised stakes. 188.97 million shares or 2.28% more from 184.77 million shares in 2017Q2 were reported. Winslow Evans And Crocker reported 0.04% of its portfolio in Incyte Corporation (NASDAQ:INCY). Sei Invs Communication stated it has 0.02% of its portfolio in Incyte Corporation (NASDAQ:INCY). 13 were reported by Brown Brothers Harriman And Company. Us Bank De invested 0% of its portfolio in Incyte Corporation (NASDAQ:INCY). Piedmont Advisors Ltd Liability holds 4,313 shares. Dekabank Deutsche Girozentrale has 0.11% invested in Incyte Corporation (NASDAQ:INCY). Millennium Mngmt Lc stated it has 341,732 shares. Savings Bank Of America Corp De holds 0.03% of its portfolio in Incyte Corporation (NASDAQ:INCY) for 1.84M shares. Van Eck Assoc Corp has invested 0.14% of its portfolio in Incyte Corporation (NASDAQ:INCY). 190,588 were reported by Manufacturers Life Insur The. State Of Tennessee Treasury Department invested in 0.03% or 46,247 shares. Louisiana State Employees Retirement Sys accumulated 10,700 shares. Keybank Natl Association Oh reported 0.01% stake. Eventide Asset Ltd invested in 40,000 shares or 0.26% of the stock. Loring Wolcott & Coolidge Fiduciary Ltd Liability Partnership Ma owns 1,339 shares or 0% of their US portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>